Serum Cytokine Profiles of Melanoma Patients and Their Association with Tumor Progression and Metastasis

Table 1

Patients and clinical characteristics.

Baseline characteristics	Melanoma patients	Healthy donors
Subjects	72	30
Age, median (range)	55 (24–88)	53 (27–85)
Sex
Male	35 (48.6%)	15 (50%)
Female	37 (51.4%)	15 (50%)
Melanoma stage, n (%)
Stage I	42(58.33%)
Stage II	11(15.28%)
Stage III	11 (15.28%)
Stage IV	8 (11.11%)
Breslow thickness
Thickness ≤1 mm	37 (69.8%)
1.01 mm–2 mm	8 (15.1%)
2.01 mm–4 mm	5 (9.7%)
>4.01 mm	3 (5.4%)
5-year survival
Alive, n (%)	55 (76.4%)
Deceased, n (%)	17 (23.6%)